1. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook
   Adhimoolam Karthikeyan et al, 2021, Pharmaceutics CrossRef
2. MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma.
   Lisa Kinget et al, 2021, Cancers (Basel) CrossRef
3. Phytochemicals as regulators of Th17/Treg balance in inflammatory bowel diseases
   Yaoyao Chang et al, 2021, Biomedicine & Pharmacotherapy CrossRef
4. Efficacy and safety of adjuvant curcumin therapy in ulcerative colitis: A systematic review and meta-analysis
   Juntao Yin et al, 2022, Journal of Ethnopharmacology CrossRef
5. pH-sensitive liposomes for colonic Co-delivery of mesalazine and curcumin for the treatment of ulcerative colitis
   Soumayya Aib et al, 2022, Journal of Drug Delivery Science and Technology CrossRef
6. Review of the Effects and Mechanism of Curcumin in the Treatment of Inflammatory Bowel Disease
   Yuan Lin et al, 2022, Front. Pharmacol. CrossRef
7. Therapeutic Potential of Curcumin in a Rat Model of Dextran Sulfate Sodium–Induced Ulcerative Colitis by Regulating the Balance of Treg/Th17 Cells
   Jing Guo et al, 2022, Inflammation CrossRef
8. Sensitization of GSH synthesis by curcumin curtails acrolein-induced alveolar epithelial apoptosis via Keap1 cysteine conjugation: a randomized controlled trial and experimental animal model of pneumonitis
   Eun Hee Jo et al, 2022, Journal of Advanced Research CrossRef
9. Traditional Chinese Medicine Regulates Th17/Treg Balance in Treating Inflammatory Bowel Disease
   Fengjiao Xie et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
10. Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis
    Yuanming Yang et al, 2022, Front. Pharmacol. CrossRef
11. MicroRNA ‐150‐5p is upregulated in the brain microvasculature during prenatal alcohol exposure and inhibits the angiogenic factor Vezf1
    Gabriela Perales et al, 2022, Alcohol Clin & Exp Res CrossRef
12. Evaluating the effects of curcumin nanomicelles on clinical outcome and cellular immune responses in critically ill sepsis patients: A randomized, double-blind, and placebo-controlled trial
    Arash Karimi et al, 2022, Front. Nutr. CrossRef
13. Efficacy of oral consumption of curcumin/ for symptom improvement in inflammatory bowel disease: A systematic review of animal models and a meta-analysis of randomized clinical trials
    MARLA DE CERQUEIRA ALVES et al, 2022 CrossRef
14. Curcumin alleviates experimental colitis in mice by suppressing necroptosis of intestinal epithelial cells
    Yuting Zhong et al, 2023, Front. Pharmacol. CrossRef
15. Dissecting specific Wnt components governing osteogenic differentiation potential by human periodontal ligament stem cells through interleukin-6
    Medania Purwaningrum et al, 2023, Sci Rep CrossRef
16. Identification of OLA1 as a Novel Protein Target of Vitexin to Ameliorate Dextran Sulfate Sodium-Induced Colitis with Tissue Thermal Proteome Profiling
    Nan Li et al, 2023, J. Agric. Food Chem. CrossRef
17. Tuning the Microstructures of Electrospray Multicore Alginate Microspheres for the Enhanced Delivery of Astaxanthin
    Hongliang Li et al, 2023, ACS Omega CrossRef
18. Shaoyao decoction alleviates TNBS-induced ulcerative colitis by decreasing inflammation and balancing the homeostasis of Th17/Treg cells
    Dongsheng Wu et al, 2023, BMC Complement Med Ther CrossRef
19. The progression of inorganic nanoparticles and natural products for inflammatory bowel disease
    Qingrong Li et al, 2024, J Nanobiotechnol CrossRef
20. Herbal Medicines for the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis
    Preetha Iyengar et al, 2024, Nutrients CrossRef
21. Animal models of inflammatory bowel disease: category and evaluation indexes
    Changlin Wen et al, 2023 CrossRef
22. Panaxynol improves crypt and mucosal architecture, suppresses colitis-enriched microbes, and alters the immune response to mitigate colitis
    Brooke M. Bullard et al, 2024, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
23. Gastrodin Attenuates Colitis and Prevents Tumorigenesis in Mice by Interrupting TLR4/MD2/NF-κB Signaling Transduction
    Zhilun Yu et al, 2024, ACAMC CrossRef
24. Raffinose Ameliorates DSS-Induced Colitis in Mice by Modulating Gut Microbiota and Targeting the Inflammatory TLR4–MyD88–NF-κB Signaling Pathway
    Peng Zhang et al, 2024, Foods CrossRef